• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Health Catalyst Acquires Clinical Workflow Optimization Solution Healthfinch

Share:

July 15, 2020

Highlights on this story:
  • Health Catalyst announces an agreement to acquire clinical workflow optimization solution healthfinch using a mix of stock and cash.
  • As part of the acquisition, healthfinch will be a new application suite category called EMR Embedded Insights and its refills, care gaps closure, and visit planning applications will continue to be available in their original configuration.

Health Catalyst, Inc., a provider of data and analytics technology and services to healthcare organizations, today announced that it has entered into a definitive agreement to acquire healthfinch, Inc., a Madison, Wisconsin-based company that provides a workflow integration engine delivering insights and analytics into EMR workflows to automate physicians’ ability to close patient care gaps in real-time. Health Catalyst expects to fund the transaction using a mix of stock and cash.

Clinical Workflow Optimization

Founded in 2011, healthfinch has developed the healthcare industry’s most trusted, most used clinical workflow optimization solution, Charlie. Charlie’s unique combination of EMR-integrated technology and protocol content streamlines key workflows such as prescription renewal processing, visit planning, and care gap closure. With Charlie, health systems are able to deliver a better, safer patient experience, while also achieving lower rates of provider and staff burnout, increased care gap closure, improved quality metrics, and significant time and cost savings for providers and clinical staff.

Integration with Health Catalyst Analytics Application Portfolio

The healthfinch acquisition, which will allow Health Catalyst’s customers to enhance clinical workflows in the EMR, further strengthens the Health Catalyst Population Health portfolio, which was bolstered by the Able Health acquisition in February 2020 and Care Management Suite launch earlier this month.

Within the Health Catalyst analytics application portfolio, healthfinch will be a new application suite category called EMR Embedded Insights and its refills, care gaps closure, and visit planning applications will continue to be available in their original configuration. Additionally, the healthfinch technology will augment workflows across Health Catalyst’s product portfolio, with data and insights powered by Health Catalyst’s cloud-based Data Operating System (DOS™), a healthcare-specific, open, flexible, and scalable data platform that provides customers with a single comprehensive environment to integrate and organize data.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

healthfinch’s industry-leading capabilities are already in demand from Health Catalyst customers and prospects across multiple product areas including quality measures, care management, population health, patient safety, and others. Providing these capabilities will bring even greater value to Health Catalyst customers by making the critical insights and analytics from the DOS platform actionable within clinical workflows – providing more effective care for patients and saving time for both doctors and staff through automation so they can work at the top of their license.

“We are thrilled to benefit from healthfinch’s decades of collective experience gained from working with customers across the United States that are using a variety of different EMRs. And we also find deeply compelling the strong mission and cultural alignment with our respected healthfinch teammates. We are excited to have the healthfinch leadership team and their talented colleagues join Health Catalyst, and we are grateful for the tremendous insights, knowledge and perspectives they bring, which will accelerate the achievement of our mission to be the catalyst for massive, measurable, data-informed healthcare improvement,” said Health Catalyst CEO Dan Burton.

Burton added, “This acquisition highlights Health Catalyst’s ability to integrate and scale software applications on top of our DOS platform. The healthfinch technology will easily serve up actionable insights, derived from DOS and other Health Catalyst analytics applications into the EMR, at the point of care.”

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce Execution of Definitive Agreement and Plan of Merger for Business CombinationTenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce Execution of Definitive Agreement and Plan of Merger for Business Combination
  • Quest Diagnostics Completes Acquisition of Mercy’s Outreach Laboratory Services BusinessQuest Diagnostics Completes Acquisition of Mercy’s Outreach Laboratory Services Business
  • Teledyne Acquires MicralyneTeledyne Acquires Micralyne
  • Pressure BioSciences Finalizes Plan to Acquire Global Eco-Friendly Agrochemical SupplierPressure BioSciences Finalizes Plan to Acquire Global Eco-Friendly Agrochemical Supplier
  • Three M&A Alternatives For Accelerating Your Digital TransformationThree M&A Alternatives For Accelerating Your Digital Transformation
  • Backed by Kaiser, Osso VR Raises $14M for VR Surgical Training PlatformBacked by Kaiser, Osso VR Raises $14M for VR Surgical Training Platform
  • Clerio Vision Acquires Manufacturer of Extreme H2O Contact LensesClerio Vision Acquires Manufacturer of Extreme H2O Contact Lenses
  • Capio completes Legevisitten acquisitionCapio completes Legevisitten acquisition

Trending This Week

  • Scotland’s Life Sciences Strategy Targets £25bn
  • Nectar Lifesciences Shares Surge on Buyback News
  • SUPRIYA Lifescience Strategic Growth Through Advanced Manufacturing
  • Investment Guide Buy Sell Hold Five Stocks
  • Supriya Lifescience Stock Analysis and Outlook
  • Eiko Lifesciences Financial Performance Analysis 2025

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications